The P&L A/C page of Wockhardt Hospitals Ltd. presents the key P&L A/c Ratios, its comparison with the sector peers and 5 years of Profit & Loss Account Statement.

Absorption of promethazine from the rectal suppositories resulted in a mean 16% lower bioavailability compared with the 50-mg oral syrup. The syrup also resulted in an earlier and higher C max and ...

Oklahoma City and Norman said goodbye to beloved breakfast spot syrup., as the restaurant closed its doors Monday. The restaurant posted to Instagram Friday announcing the closures. "It is with heavy ...

It was then that the Children’s Hospital of Orange County in California sought special permission to use an experimental drug — Zaynich — developed by Indian pharmaceutical company Wockhardt. Within ...

Local and federal authorities conducting an investigation into drug trafficking in Orleans Parish arrested two men and seized guns, a cache of illegal narcotics including fentanyl and more than $ ...

Wockhardt Ltd. expects a boost to revenue from its new drug to fight pneumonia-causing superbugs in India, where rampant use of antibiotics has made the population vulnerable to antimicrobial ...

Drug firm Wockhardt on Wednesday reported a consolidated net loss of Rs 16 crore for the second quarter ended September 30, 2024. The company has reported a net loss of Rs 73 crore in July-September ...

After enrollment and completion of study period 1 (treatment D, 50 mg [10 mL] of promethazine oral syrup), one subject was withdrawn from the study because of violation of study protocol.

Wockhardt Ltd. expects around Rs 400 crore revenue from its new generation oral antibiotic, Nafithromycin, in the next two to three years, according to Founder and Chairman Kabil Kharoiwala. The drug, ...